V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006238 | 280003841 | 1.6 | 84.9 | Curative (C) | 2016-11-08 | 2016-11-09 | GemCarbo Days 1+8 | N | N | 280030528 | EURO-EWING |
| 280006239 | 280003842 | 0 | 92 | Adjuvant (A) | 2014-12-26 | 2014-12-26 | Docetaxel+Gemcitabine (no prior RT) | N | N | 280030534 | CAPECITABINE + OXALIPLATIN |
| 280006240 | 280003843 | 1.65 | 86.6 | null | 2017-06-16 | 2017-07-05 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | Y | 280030535 | MELPHALAN |
| 280006241 | 280003843 | 1.7 | null | Palliative (P) | 2013-06-12 | 2013-06-12 | PACLITAXEL | N | N | 280030535 | OXALIPLATIN + MDG |
| 280006242 | 280003843 | 1.7 | 90 | Palliative (P) | 2015-04-25 | 2015-05-14 | CompARE Trial | 02 | N | 280030535 | DOXORUBICIN + OLARATUMAB |
| 280006243 | 280003843 | 1.7 | 87.2 | Palliative (P) | 2016-12-28 | 2017-01-07 | Carboplatin + Pemetrexed | 2 | N | 280030535 | BRENTUXIMAB |
| 280006244 | 280003844 | 1.7 | 80.8 | Palliative (P) | 2013-09-14 | 2013-10-02 | CompARE Trial | N | N | 280030544 | CISPLATIN + FLUOROURACIL + RT |
| 280006245 | 280003844 | 1.8 | 84 | Palliative (P) | 2017-09-19 | 2017-09-20 | Capecitabine | 2 | N | 280030544 | CAV |
| 280006246 | 280003845 | null | null | Curative (C) | 2014-04-04 | 2014-04-19 | Carboplatin + Pemetrexed | N | N | 280030546 | DARS TRIAL |
| 280006247 | 280003846 | null | 69.2 | Neo-adjuvant (N) | 2017-08-20 | 2017-08-23 | STS Rhabdomyosarcoma RMS 2005 IVA | N | null | 280030547 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 280006248 | 280003846 | 1.67 | null | Curative (C) | 2013-11-20 | 2013-12-10 | Capecitabine | N | Y | 280030547 | CISPLATIN + VINORELBINE |
| 280006249 | 280003846 | 1.81 | 19.5 | Palliative (P) | 2017-01-16 | 2017-02-03 | LANREOTIDE | N | N | 280030547 | CAPECITABINE + CARBOPLATIN |
| 280006250 | 280003847 | 1.73 | 64 | Palliative (P) | 2017-05-19 | 2017-05-23 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | Y | 280030552 | CVD |
| 280006251 | 280003847 | null | 108.4 | Neo-adjuvant (N) | 2017-10-13 | 2017-10-20 | Oxaliplatin + Modified de Gramont | 2 | N | 280030552 | PACLITAXEL |
| 280006255 | 280003849 | 1.78 | 39.2 | Palliative (P) | 2017-11-19 | 2017-11-19 | Capecitabine (14 days)+Carboplatin | N | N | 280030561 | GEDDIS TRIAL |
| 280006256 | 280003850 | 1.8 | 84.8 | Neo-adjuvant (N) | 2014-12-27 | 2015-08-04 | CAPECITABINE + OXALIPLATIN | N | N | 280030563 | CISPLATIN + DOCETAXEL |
| 280006257 | 280003850 | 1.76 | 87.2 | Palliative (P) | 2013-10-22 | 2013-10-27 | Mitomycin Intravesical | N | N | 280030563 | CARBOPLATIN + DOCETAXEL |
| 280006258 | 280003851 | 1.87 | 0 | Palliative (P) | 2015-02-26 | 2015-02-27 | Irinotecan + Modified De Gramont | 02 | N | 280030565 | CISPLATIN + PEMETREXED |
| 280006259 | 280003852 | null | null | null | null | 2017-07-15 | CAPECITABINE + OXALIPLATIN | null | null | 280030566 | GEMCARBO |
| 280006260 | 280003853 | 1.75 | 81.7 | Curative (C) | 2013-03-24 | 2013-04-07 | LANREOTIDE | 02 | N | 280030568 | CISPLATIN + ETOPOSIDE |
| 280006261 | 280008101 | 1.58 | null | Palliative (P) | 2017-06-24 | 2017-06-30 | Carboplatin + Pemetrexed | N | N | 280030569 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 280006262 | 280003854 | 1.75 | 54.9 | Neo-adjuvant (N) | null | 2014-10-09 | VIDE | 01 | null | 280030570 | CAV |
| 280006263 | 280003854 | 1.54 | 60.8 | Palliative (P) | 2017-11-19 | 2017-11-19 | Doxorubicin + Olaratumab | N | N | 280030570 | VDC |
| 280006264 | 280003854 | null | null | Disease modification (D) | 2015-06-14 | 2015-06-14 | DA 3+8 | N | null | 280030570 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 280006265 | 280003855 | 1.77 | 86.8 | Curative (C) | 2014-11-27 | 2014-12-09 | ECX | N | N | 280030573 | CISPLATIN + FLUOROURACIL + RT |
| 280006266 | 280008103 | 1.73 | 70.9 | Adjuvant (A) | 2014-07-12 | 2014-07-13 | VIDE | 2 | N | 280030574 | BCG |
| 280006267 | 280003856 | 1.75 | 87.4 | Palliative (P) | null | 2017-01-13 | CARBOPLATIN + Cetuximab + FLUOROURACIL | Y | Y | 280030581 | CAPECITABINE + CISPLATIN |
| 280006268 | 280003856 | 1.85 | 104 | Palliative (P) | 2016-11-25 | 2016-11-26 | DE-ESCALATE TRIAL | N | null | 280030581 | CARBOPLATIN + PEMETREXED |
| 280006269 | 280003857 | 1.75 | 77.6 | Palliative (P) | 2015-08-10 | 2015-08-15 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | N | N | 280030587 | CARBO + FLUOROURACIL |
| 280006270 | 280003857 | null | 107 | Curative (C) | 2017-03-05 | 2017-03-25 | Liposomal Doxorubicin 50mg/m2 | Y | null | 280030587 | CISPLATIN + FLUOROURACIL + RT |
| 280006271 | 280003858 | 1.59 | null | Not known (9) | null | 2016-01-28 | Ipilimumab | null | null | 280030591 | LENALIDOMIDE |
| 280006272 | 280003858 | null | 62.4 | null | 2016-09-19 | 2016-09-19 | Mitomycin Intravesical | N | N | 280030591 | IVADO |
| 280006273 | 280003858 | 1.65 | null | Adjuvant (A) | 2016-02-08 | 2016-03-06 | CYCLOPHOSPHAMIDE + VINORELBINE | N | N | 280030591 | PATHOS TRIAL |
| 280006274 | 280003858 | 1.6 | 84 | Palliative (P) | 2015-04-09 | 2015-04-09 | EW EuroEwing 2012 Arm A VIDE | N | N | 280030591 | BENDAMUSTINE + RITUXIMAB |
| 280006275 | 280003859 | null | 101.5 | Curative (C) | 2017-03-06 | 2017-03-06 | FLUOROURACIL + OXALIPLATIN | N | N | 280030598 | RMS 2005 TRIAL |
| 280006276 | 280003859 | 1.58 | 63 | Palliative (P) | 2014-05-10 | 2014-05-23 | CompARE Trial | N | N | 280030598 | DOXORUBICIN + OLARATUMAB |
| 280006277 | 280003860 | 1.71 | 63.7 | Palliative (P) | 2015-10-06 | 2015-10-06 | VIDE | 02 | null | 280030602 | PACLITAXEL |
| 280006278 | 280003860 | 1.67 | 63.7 | Adjuvant (A) | 2015-10-09 | 2015-10-09 | CAPECITABINE + CARBOPLATIN | 02 | N | 280030602 | DE-ESCALATE TRIAL |
| 280006279 | 280003861 | null | 82.25 | Curative (C) | 2013-01-21 | 2013-02-08 | VAC | N | N | 280030607 | CARBO + FLUOROURACIL |
| 280006280 | 280003861 | 1.65 | 76.3 | Palliative (P) | 2014-08-19 | 2014-09-09 | GEMCARBO | 2 | N | 280030607 | PACLITAXEL |
| 280006281 | 280003861 | 1.71 | 52 | Curative (C) | 2014-11-19 | 2014-11-19 | Cisplatin + Pemetrexed | 01 | N | 280030607 | TCF |
| 280006282 | 280003861 | 1.79 | null | Curative (C) | 2017-10-14 | 2017-10-15 | IVADo | null | null | 280030607 | DE-ESCALATE TRIAL |
| 280006284 | 280003863 | null | null | Curative (C) | 2017-11-27 | 2017-12-02 | Ifosfamide | N | null | 280030615 | DE-ESCALATE TRIAL |
| 280006285 | 280003864 | 0 | 93.5 | Palliative (P) | 2015-08-04 | 2015-08-15 | CISPLATIN + FLUOROURACIL + RT | N | N | 280030616 | DOXORUBICIN + OLARATUMAB |
| 280006286 | 280003865 | 1.65 | 0 | Curative (C) | 2014-07-17 | 2014-07-17 | Capecitabine | 02 | N | 280030618 | EURO-EWING |
| 280006287 | 280008110 | 1.68 | 100 | Palliative (P) | 2016-09-10 | 2016-09-16 | Docetaxel+Gemcitabine (no prior RT) | N | N | 280030619 | LIPOSOMAL DOXORUBICIN |
| 280006288 | 280008110 | 1.54 | 74.8 | Palliative (P) | 2018-04-02 | 2018-04-16 | Paclitaxel 7 day | N | null | 280030619 | PACLITAXEL |
| 280006289 | 280003866 | 1.54 | 41.5 | null | 2014-04-05 | 2014-04-05 | IPILIMUMAB + NIVOLUMAB | 2 | N | 280030622 | FLUOROURACIL + MITOMYCIN + RT |
| 280006290 | 280003867 | 1.8 | 93.5 | Palliative (P) | 2016-06-27 | 2016-07-05 | Mitomycin Intravesical | 02 | N | 280030624 | CAPECITABINE |
| 280006291 | 280003868 | 1.76 | null | Palliative (P) | 2018-08-24 | 2018-08-24 | Gemcitabine weekly | 02 | N | 280030627 | CARBOPLATIN + CETUXIMAB + FU |